Let's be real here, this is a multiple phase 3 Biotech, one already commenced funded by the WHO, one due to commence in the coming days/weeks, and 2 in the planning/organising stage and we outstanding previous data, and our market cap is $50m. it is criminally undervalued. Yes a few (including me) was disappointed with the share price action after the last trial (which still garnered good results) we have been presented with the buying opportunity of a lifetime. I never expected to own any more DXB shares going into previous trial results but I've been accumulating like a mad man ever since. Unbelievable
DXB Chart, page-9
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.010(2.78%) |
Mkt cap ! $192.3M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.0¢ | 34.0¢ | $1.977M | 5.663M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 1445485 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 24999 | 1 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
34.5¢ |
Change
-0.010 ( 4.14 %) |
||||
| Open | High | Low | Volume | ||
| 36.5¢ | 37.0¢ | 34.0¢ | 2600347 | ||
| Last updated 15.59pm 06/05/2024 ? | |||||
| DXB (ASX) Chart |